These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10508301)

  • 1. Blood pool contrast agents for cardiovascular MR imaging.
    Kroft LJ; de Roos A
    J Magn Reson Imaging; 1999 Sep; 10(3):395-403. PubMed ID: 10508301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR angiography with blood pool contrast agents.
    Bremerich J; Bilecen D; Reimer P
    Eur Radiol; 2007 Dec; 17(12):3017-24. PubMed ID: 17639407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal MR angiography performed using blood pool contrast agents: comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer.
    Nolte-Ernsting C; Adam G; Bücker A; Berges S; Bjørnerud A; Günther RW
    AJR Am J Roentgenol; 1998 Jul; 171(1):107-13. PubMed ID: 9648772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
    Bremer C; Allkemper T; Baermig J; Reimer P
    J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits.
    Clarke SE; Weinmann HJ; Dai E; Lucas AR; Rutt BK
    Radiology; 2000 Mar; 214(3):787-94. PubMed ID: 10715047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic physics of MR contrast agents and maximization of image contrast.
    Hendrick RE; Haacke EM
    J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol.
    Corot C; Violas X; Robert P; Gagneur G; Port M
    Invest Radiol; 2003 Jun; 38(6):311-9. PubMed ID: 12908698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
    Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
    J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial perfusion and MR angiography of chest with SH U 555 C: results of placebo-controlled clinical phase i study.
    Reimer P; Bremer C; Allkemper T; Engelhardt M; Mahler M; Ebert W; Tombach B
    Radiology; 2004 May; 231(2):474-81. PubMed ID: 15044749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
    Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
    Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection.
    Panting JR; Taylor AM; Gatehouse PD; Keegan J; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 1999 Sep; 10(3):404-10. PubMed ID: 10508302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography.
    Taylor AM; Panting JR; Keegan J; Gatehouse PD; Amin D; Jhooti P; Yang GZ; McGill S; Burman ED; Francis JM; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 1999 Feb; 9(2):220-7. PubMed ID: 10077017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the efficacy of MRI contrast agents in MRA.
    Weinmann HJ; Bauer H; Ebert W; Frenzel T; Radüchel B; Platzek J; Schmitt-Willich H
    Acad Radiol; 2002 May; 9 Suppl 1():S135-6. PubMed ID: 12019849
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced 3D-TOF MRA of peripheral vessels: intravascular versus extracellular MR contrast media.
    Engelbrecht MR; Saeed M; Wendland MF; Canet E; Oksendal AN; Higgins CB
    J Magn Reson Imaging; 1998; 8(3):616-21. PubMed ID: 9626876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
    Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
    Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of iron oxide particles (AMI 227) with a gadolinium complex (Gd-DOTA) in dynamic susceptibility contrast MR imagings (FLASH and EPI) for both phantom and rat brain at 1.5 Tesla.
    Loubeyre P; De Jaegere T; Bosmans H; Miao Y; Ni Y; Landuyt W; Marchal G
    J Magn Reson Imaging; 1999 Mar; 9(3):447-53. PubMed ID: 10194716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: experimental study in rabbits.
    Loubeyre P; Zhao S; Canet E; Abidi H; Benderbous S; Revel D
    J Magn Reson Imaging; 1997; 7(6):958-62. PubMed ID: 9400837
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.